MERSANA THERAPEUTICS INC. - COMMON STOCK
3.3400
18-April-24 15:59:59
15 minutes delayed
Stocks
-0.1800
-5.11%
Today's range
3.3150 - 3.5584
ISIN
N/A
Source
NASDAQ
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Apr 2024 16:30:28 By Nasdaq GlobeNewswire
-
28 Feb 2024 07:00:08 By Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
27 Feb 2024 08:01:15 By Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024
21 Feb 2024 08:00:22 By Nasdaq GlobeNewswire
-
Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference
01 Feb 2024 08:00:46 By Nasdaq GlobeNewswire
-
05 Jan 2024 08:01:19 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Dec 2023 16:30:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results
07 Nov 2023 07:00:55 By Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Third Quarter 2023 Conference Call on November 7, 2023
31 Oct 2023 16:30:25 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces FDA has Lifted Clinical Hold on Phase 1 Clinical Trial of XMT-2056
31 Oct 2023 08:00:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Changes in Leadership
06 Sep 2023 07:00:40 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
08 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Aug 2023 16:05:52 By Nasdaq GlobeNewswire
-
27 Jul 2023 07:06:23 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Jul 2023 16:05:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials
15 Jun 2023 07:30:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Jun 2023 16:05:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
24 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
09 May 2023 07:00:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 May 2023 16:05:01 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >